Obesity News

PHILADELPHIA — Some dietary change may improve cardiometabolic measures beyond weight loss and providers should create a diet that will most benefit each individual with obesity, according to a speaker.

PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference.

PHILADELPHIA — In this Healio video exclusive, Neha J. Pagidipati, MD, MPH, highlights growing evidence on the relationship between weight change and risk for cardiovascular disease.

Patients who were prescribed phentermine after losing fewer than 20 pounds while on a GLP-1 receptor agonist were more likely to lose weight 1 year after GLP-1 discontinuation than those who were not prescribed phentermine, recent findings show.

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.

Patients with obesity are at increased risk for CVD, in part due to the promotion of an atherogenic lipid profile, according to a speaker.

Insufficient sleep was tied to poorer cognition and attention in adolescents who were classified as having overweight or obesity based on their BMI compared with those with normal weight, according to a recent study in JAMA Neurology.

The FDA has authorized CamAPS FX, a closed loop algorithm that links compatible continuous glucose monitors and insulin pumps into an artificial pancreas system for patients with type 1 diabetes aged 2 years and older.

A new study in the Journal of Osteopathic Medicine showed that higher BMIs before pregnancy correlated with increasing risks for maternal and neonatal morbidity.